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Abstract 
Metabolic syndrome is a serious health problem in the United States. The 
presence of metabolic syndrome significantly increases the risk of developing type II 
diabetes and cardiovascular disease by producing a prothrombic state. The prothrombic 
state that results from the clustering of several independent cardiovascular risk factors 
within one individual increases the risk of micro and macro vascular changes and 
eventually to end organ damage.  
There is considerable evidence to support the serious nature of this medical 
condition. Medications used to treat the hypertension, diabetic, and dyslipidemia 
components of metabolic syndrome can be a significant drain on the monthly budget of 
individuals and families, especially if they do not have health insurance. Diet and 
exercise programs have been shown to be effective in reducing adiposity and decreasing 
insulin resistance. These changes in lifestyle may be adjuncts or a low cost alternative to 
expensive medications for some individuals. The purpose of this project was to identify 
the effect of an intensive dietary and exercise program on patients with metabolic 
syndrome. 
This study even with a small sample size (n = 5) showed that waist size, systolic 
blood pressure, diastolic blood pressure, and high density lipoprotein levels were trending 
towards levels that would remove the patient from the diagnosis of metabolic syndrome. 
The greatest benefit for the general population would result from intervention prior to a 
diagnosis of hypertension and diabetes and with medication naïve individuals. Early 
intervention would decrease the cost of medical treatment and hospitalizations.  
 
 
 
 
Chapter One: Introduction 
Metabolic syndrome is the grouping of interrelated metabolic risk factors within a single 
individual. The metabolic syndrome, first described in the 1920s, has been the subject of 
extensive research since the mid to late 1990’s (Johnson & Weinstock, 2006). This clustering of 
risk factors increases the risk of developing type II diabetes (DM II) and coronary heart disease 
(CHD) (Stone & Schmeltz, 2007). Four expert groups have developed diagnostic definitions: 
The National Cholesterol Educational Program’s Adult Treatment Panel III (ATP III), the 
International Diabetes Federation (IDF), the American Heart Association/National Heart, Lung, 
and Blood Institute (NCEP-R), and the World Health Federation (WHO).  
The ATP III, NCEP-R, and IDF use waist circumference, triglyceride level, HDL 
cholesterol level, blood pressure, and fasting glucose as diagnostic criteria. The WHO criteria 
include these same five elements as well as, microalbuminuria as a sixth factor. Thus, there is no 
genuine consensus within the health care community as to what components comprise metabolic 
syndrome (Guize et al., 2007). These varying definitions make comparing studies difficult and 
add confusion when diagnosing metabolic syndrome. Table 1.1 presents the diagnostic criteria 
for metabolic syndrome from these four organizations.  
Three of five diagnostic criteria or markers are necessary to make the diagnosis of 
metabolic syndrome using the NCEP-R definition. Treatment should target modifiable risk 
factors in an effort to place the patient outside the diagnostic criteria.  
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Table 1.1 
Comparison of ATP III, NCEP-R, IDF, and WHO Diagnostic Criteria for Metabolic Syndrome 
Organization Waist Circumference Triglycerides HDL Cholesterol Blood Pressure Fasting Glucose 
Diagnostic 
Criteria 
ATP III 
Men >102 cm 
Women > 88 cm 
Men & Women 
>/= 150 
Men < 40 mg/dl 
Women < 50 mg/dl 
SBP >/= 130  
DBP >/= 85  
Glucose >/= 110  Three of the 
five  
NCEP-R 
Men >102 cm 
Women > 88 cm 
Men & Women 
>/= 150, 
or 
Treatment for 
elevated 
triglycerides 
Men < 40 mg/dl 
Women < 50 mg/dl 
or 
Treatment for low 
HDL 
SBP >/= 130 
DBP >/= 85  
or 
Treatment for 
HTN 
Glucose >/= 100  
or 
Treatment for 
elevated glucose 
Three of the 
five  
IDF 
Men >94 cm 
Women > 80 cm 
Men & Women 
>/= 150, 
or 
Treatment for 
elevated 
triglycerides 
Men < 40 mg/dl 
Women < 50 mg/dl 
or 
Treatment for low 
HDL 
SBP >/= 130  
DBP >/= 85  
or 
Treatment for 
HTN 
Glucose >/= 100  
or 
Diagnosis of 
diabetes 
Presence of 
abdominal 
obesity and 
two of the 
remaining four 
Fasting 
glucose or 
Insulin 
resistant plus 
two additional 
criteria 
WHO 
BMI > 30 kg/m2 or 
Waist-to-hip ratio 
     Men > 0.90, 
     Women > 0.85  
Men & Women 
>/= 150, 
or 
Treatment for 
elevated 
triglycerides 
Men < 35 mg/dl 
Women < 39 mg/dl 
BP >/= 
140/90 
Diabetes or 
Impaired fasting 
glucose or 
Impaired glucose 
tolerance test 
*WHO criteria also include as a sixth criteria – Microalbuminuria > 30 mg albumin/g creatinine 
From: “All-cause Mortality Associated with Specific Combinations of the Metabolic Syndrome According to Recent Definitions,” by 
L. Guize, F. Thomas, B Pannier, K. Bean, B. Jego, & A. Bentos, (2007), Diabetes Care, 30, 2382. 
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Ideally treatment should begin prior to a diagnosis of hypertension and/or 
diabetes. Dietary interventions to reduce caloric intake and thereby reducing circulating 
plasma glucose levels and waist circumference should be undertaken as early as possible. 
For individuals with elevated blood pressure and/or hypertension, dietary salt reduction to 
help reduce or prevent hypertension is an excellent initial intervention. Aerobic exercise 
three to five times a week for 30 to 60 minutes has been shown to increase HDL, as well 
as reduce circulating plasma glucose levels, triglycerides, and minimally reduce LDL 
cholesterol (Carroll & Dudfield, 2004). 
Purpose 
The purpose of this project was to identify the effects of an intensive dietary and 
exercise program on patients with metabolic syndrome. Specifically, the project was to 
examined the effects of the program on waist circumference, blood pressure, HDL 
cholesterol, triglycerides, and fasting glucose. 
Definition of Terms  
 Metabolic syndrome. For the purposes of this project, the diagnosis of metabolic 
syndrome was made based on the NCEP-R definition, that is, the presence of three or 
more of the five diagnostic criteria (see Table 1.1). 
 Intensive dietary program. For the purposes of this project, a dietary plan was 
designed for each study participant. It was designed to provide flexibility and be 
constructed based on Mediterranean style diet principles. The dietitian provided 
information on frequency of consumption of foods in specific food groups, serving sizes, 
and number of servings. Suggested meal and snack patterns and food lists were 
4 
determined for each participant based on local, ethnic, and personal preferences, as well 
as socioeconomic constraints.  
 Mediterranean style diet. For the purposes of this project, the Mediterranean style 
diet was defined as a diet consisting of a large amount of plant foods (i.e. fruits, 
vegetables, nuts, and beans), minimal amounts of processed foods, a low to moderate 
quantity of dairy products and less than four eggs per week. A limited amount of red 
meat was recommended. Wine with meals in a low to moderate amount was acceptable. 
Fresh fruit was recommended as a desert rather than concentrated sugars. 
 Intensive exercise program. For the purposes of this project, the intensive exercise 
program is defined as a minimum of 30 to 60 minutes of exercise conducted at a 
moderate level. The exercise can be dispersed throughout the day in no less than 10 
minute segments. Individuals was urged to exercise at least three and preferably five days 
a week.  
 Moderate physical activity. For the purposes of this project, moderate physical 
activity is defined as walking briskly about 3 ½ miles per hour, hiking, gardening/yard 
work, dancing, playing golf while walking and carrying clubs, bicycling at less than 10 
miles per hour, and weight training. 
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Chapter Two: Review of Literature 
 This chapter contains an overview of the search strategies used for identification 
and retrieval of the evidence. This was followed by a brief overview of cardiovascular 
disease and a review of the evidence with respect to the effects of metabolic syndrome on 
cardiovascular disease. A discussion of the relationship between socioeconomic position 
and metabolic syndrome was followed by a synthesis of the evidence for non-
pharmacologic interventions, the Mediterranean style diet and exercise.  
Search Strategies 
 A systematic search of CINAHL, Medline, ProQuest, and the Cochrane Library 
was conducted for the period January 2000 through March 2008 using the key words 
metabolic syndrome or syndrome X. A search of Medline for meta-analyses published in 
the English language returned a total of 10 items. When this search was further restricted 
to diet or dietary and metabolic syndrome or syndrome X, three items were returned. A 
search of the Cochrane Library database with these same parameters returned one 
Cochrane Review. 
 The ProQuest search, limited to full text documents published in scholarly peer-
reviewed journals returned a total of 1641 items. When the search was limited by Top 
Journals instead of Scholarly Journals the total number of items was reduced to 504. A 
search of the Cochrane Library database returned 234 clinical trials. 
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 After accounting for duplications of resources across databases, a total of 5 
systematic reviews and meta-analyses were reviewed. A total of 15 studies and additional 
articles were also reviewed. 
Cardiovascular Disease: An Overview 
 The U.S. Department of Health and Human Services (USDHHS, 2005) identified 
heart disease and stroke as the principle components of cardiovascular disease. Heart 
disease is the leading cause of death in both men and women in the United States and 
stroke is the third leading cause of death. These two components of cardiovascular 
disease account for nearly 930,000 American deaths each year (USDHHS, 2005). This is 
almost 40% of all deaths and amounts to approximately one death every 33 seconds. The 
burden of heart disease and stroke would be lessened considerably if the major risk 
factors were reduced. These risk factors include high blood pressure, high cholesterol, 
diabetes, physical inactivity, poor nutrition, and tobacco use.  
 In 2005 more than $394 billion was the projected cost of heart disease and stroke. 
This includes $152 billion in lost productivity and $242 billion in health care 
expenditures. Hypertension was responsible for an additional $60 billion in health care 
spending in 2005 (USDHHS, 2005). A 21% decline in coronary heart disease, a 37% 
decline in stroke, and a 25% decline in cardiovascular deaths would result from a 
reduction of systolic blood pressure by 12 – 13 mmHg maintained over a 4 year period 
(USDHHS, 2005). 
Metabolic Syndrome and Cardiovascular Disease  
Metabolic syndrome increases the risk of diabetes and cardiovascular disease 
even in the absence of diabetes. Gami et al. (2007), in their systematic review and meta-
7 
analysis, identified 4,198 articles and determined that 104 were potentially relevant to 
their question of the association between metabolic syndrome and cardiovascular events. 
Of these, 67 were either cross-sectional designs or contained no data with reference to 
metabolic syndrome or cardiovascular outcomes and one study was rejected because it 
had the identical study cohort as a previously published study. This left a total of 36 
articles to be included in the analysis. Diagnostic criteria varied between studies and 
included WHO, NCEP-R, ATP III, as well as others which were not defined.  
The outcomes of interest in this review were CV event, CHD event, CV death, 
CHD death, and death (Gami et al., 2007). After ensuring heterogeneity between the 
studies, the relative risk (RR) for the five outcomes was determined to be 1.60 to 2.18 (CI 
1.28-2.01 and 1.63-2.93 respectively).  The RR for cardiovascular events and death were 
significantly different between those studies that employed the WHO and NCEP criteria 
as compared to the other criteria. The large inconsistencies between the findings of 
studies that use the WHO criteria and the studies that use the NCEP criteria could not be 
explained merely by the use of different obesity metrics (see Table 2.1).  
Gami et al. (2007) also found that the evidence, drawn from a significant number 
of longitudinal studies, which included 172,573 people, indicated a significant increase in 
the risk of cardiovascular events and death in people with metabolic syndrome and that 
cardiovascular risk was a third higher for women with metabolic syndrome than for men. 
The authors determined that use of the WHO criteria was more precise in predicting 
cardiovascular events and death than the ATP III criteria. The substitution of BMI (body 
mass index) for other measures of obesity did not adversely affect the results.  
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Table 2.1 
 
Relative Risk and Confidence Interval by Outcome in the Gami et al. Systematic Review 
 
Outcome Studies n RR 95% CI 
CV event 11 2.18 1.63-2.93 
CHD event 18 1.65 1.37-1.99 
CV death 10 1.91 1.47-2.49 
CHD death 7 1.60 1.28-2.01 
Death 12 1.60 1.37-1.92 
From: “Metabolic syndrome and risk of incident cardiovascular events and death: A 
systematic review and meta-analysis of longitudinal studies,” A. Gami, B. Witt, D. 
Howard, P. Erwin, L. Gami, V. Somers, et al. (2007). Journal of the American College of 
Cardiology, 49, 409.  
 
 In contrast to the findings of Gami et al. (2007), Lorenzo, Williams, Hunt, and 
Haffner (2007) found equal effectiveness of the IDF, ATP III, and WHO diagnostic 
criteria in predicting CVD in their secondary analysis of data from the San Antonio Heart 
Study. This was a 12-year longitudinal study of 2941 individuals between the ages of 25 
and 64. The researchers hypothesized that the combination of metabolic syndrome and 
age (equal to or greater than 45 for men; 55 for women) could be used as a good marker 
for cardiovascular disease (CVD) risk. They also postulated that metabolic syndrome plus 
impaired fasting glucose (IFG) would be a better predictor of diabetes than either 
parameter alone. The researchers applied the ATP III, IDF, and WHO diagnostic criteria 
for metabolic syndrome. The predictive value of metabolic syndrome alone was then 
compared to the predictive value of the Framingham 10-year risk assessment as a means 
to predict CVD. The American Diabetes Association 2003 criterion for diagnosis of 
diabetes was used (Gami et al. (2007). The development of CVD was assessed in 2,559 
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of the 2,941 study participants; diabetes was assessed in 1,709 of the 2,459 non-diabetic 
individuals in the original study.  
New onset CVD was diagnosed in 93 (8.5%) men and 63 women (4.3%) for a 
combined incidence of 6.1% (Lorenzo et al, 2007).  Metabolic syndrome was not 
predictive of new CVD events in individuals with existing coronary heart disease (CHD) 
and/or CHD risk equivalents. In individuals who did not have CHD or CHD risk 
equivalents the odds ratios (OR) were similar when either the ATP III, WHO, or IDF 
criteria was used (see Table 2.2). Sensitivity was higher for the IDF criteria.  
Table 2.2 
 
Metabolic Syndrome Definition Predictive of Cardiovascular Disease by Definition in the 
San Antonio Heart Study 
 
Definition Odds Ratio (OR) 95% Confidence Interval (CI) 
ATP III 2.00 1.33 – 3.01 
IDF 1.69 1.13 – 2.54 
WHO  1.73 1.12 – 2.67 
From: “The National Cholesterol Education Program-Adult Treatment Panel III, 
International Diabetes Federation, and World Health Organization definitions of the 
metabolic syndrome as predictors of incident cardiovascular disease and diabetes,” C. 
Lorenzo, K. Williams, K. Hunt, & S. Hafner. (2007). Diabetes Care, 30, 9. 
 
When metabolic syndrome and age were considerated together this increased the 
ability to predict CVD (see Table 2.3). CVD risk predicted by metabolic syndrome alone 
had inferior predictive value for CVD risk when compared to the predictive value of the 
Framingham score.  
Diabetes developed in 11.4% of the subjects. The predictive value of developing 
diabetes by the presence of metabolic syndrome alone was similar to the predictive value 
using the two hour glucose tolerance test value. All definitions had similar predictive 
10 
value for diabetes, except again IDF had increased sensitivity. Lorenzo et al. (2007) 
determined that an improved risk assessment for diabetes may be better accomplished by 
considering all individuals with glucose intolerance and or metabolic syndrome at a high 
risk for the development of diabetes.  
Table 2.3 
 
Metabolic Syndrome Plus Age Predictive of Cardiovascular Disease by Definition: From 
the San Antonio Heart Study 
Men Age > 45 Women Age > 55 
Definition 
OR 95% CI OR 95% CI 
ATP III 9.25 4.85 – 17.7 4.98 2.08 – 12.0 
IDF 9.55 5.09 – 17.9 4.40 1.92 – 10.1 
WHO 6.47 3.30 – 12.7 5.85 2.28 – 15.0 
From: “The National Cholesterol Education Program-Adult Treatment Panel III, 
International Diabetes Federation, and World Health Organization definitions of the 
metabolic syndrome as predictors of incident cardiovascular disease and diabetes,” C. 
Lorenzo, K. Williams, K. Hunt, & S. Hafner. (2007). Diabetes Care, 30, 8. 
 
A limitation of the study was that the CVD data were obtained by questionnaire 
and review of death certificates. The confidence intervals were wide when predicting 
CVD risk in women. 
 Simons, Simons, Friedlander, and McCallum (2007) conducted a 16 year cohort 
study with 2805 individuals over the age of 60 in Dubbo, New South Wales, Australia to 
determine if a diagnosis of the metabolic syndrome provided additional predictive value 
of cardiovascular disease and total mortality in the elderly above that normally associated 
with the known risk factors. The researchers used the NCEP-R definition of metabolic 
syndrome with the exception that BMI was used instead of waist circumference, with 
29.3 kg/m2  as a reference point for central obesity. Hospitalization and death records 
were continuously monitored and mail surveys were conducted every 2 years.  
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Greater than 95% of the surviving participants were traceable during the last 
survey (Simons et al., 2007). A total of 384 men (31%) and 536 women (34%) were 
diagnosed with metabolic syndrome. Of these, 211 men (55%) and 259 women (48%) 
had CHD, 269 men (18%) and 91 women (17%) had ischemic stroke, and total mortality 
was for men was 256 (67%) and for women 275 (51%). All outcomes were more frequent 
when metabolic syndrome was present in all age groups except for those > 80 year-of-
age, but this group was also the fewest in number (see Table 2.4). After controlling for 
age, metabolic syndrome was a significant predictor of CHD in both men and women. 
Simons et al. (2007) concluded that a diagnosis of metabolic syndrome in older people is 
a good predictor of coronary heart disease, stroke, and total mortality over and above any 
other risk factors.  
Metabolic Syndrome and Socioeconomic Position  
 A review of studies reflecting approximately 194,000 individuals in the United 
States, Senegal, and Europe literature found an inverse relationship between smoking 
prevalence, a health behavior, and socioeconomic status (SES) (Kaplan & Keil, 1993). In 
1987 the prevalence of smoking was 35.7% among non-high school graduates and 16.3% 
among college graduates. Decreases in smoking from 1974 to 1985 were greater among 
college graduates (10.1%) than those with less than a high school education (1.1%). 
Kaplan and Keil (1993) also found an inverse relation between SES and high blood 
pressure.  
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Table 2.4 
 
Event Prediction by Number of Component Variables of Metabolic Syndrome in the New 
South Wales Study 
MEN Women 
Number of 
components 
CHD Stroke Mortality CHD Stroke Mortality 
0 1.00 1.00 1.00 1.00 1.00 1.00 
1 
1.84 
(1.12 – 
3.01) 
0.94 
(0.50 – 
1.78) 
1.41 
(0.96 – 
2.06) 
1.55 
(0.93 – 
2.59) 
2.14 
(0.92 – 
4.95) 
1.03 
(0.70 – 
1.53) 
2 
1.85 
(1.13 – 
3.05) 
1.07 
(0.57 – 
2.01) 
1.50 
(1.02 – 
2.20) 
1.97 
(1.18 – 
3.28) 
1.97 
(0.84 – 
4.64) 
1.26 
(0.85 – 
1.87) 
3 
2.83 
(1.71 – 
5.04) 
1.01 
(0.51 – 
2.00) 
2.15 
(1.45 – 
3.19) 
2.42 
(1.45 – 
4.04) 
2.12 
(0.90 – 
5.03) 
1.23 
(0.82 – 
1.84) 
4 or 5 
3.00 
(1.79 – 
5.04) 
1.78 
(0.91 – 
3.48) 
2.14 
(1.42 – 
3.23) 
3.68 
(2.19 – 
6.20) 
3.84 
(1.61 – 
9.15) 
2.06 
(1.37 – 
3.11) 
Note. Values are hazard ratios and 95% confidence intervals. 
From: “Does a diagnosis of the metabolic syndrome provide additional prediction of 
cardiovascular disease and total mortality in the elderly? The Dubbo Study,” L. Simons, 
J. Simons, Y. Friedlander, & J. McCallum, (2007). Medical Journal of Australia, 186, 
402. 
 
 Loucks, Rehkopf, Thurston, and Kawachi (2006) found that socioeconomic 
position (SEP) is associated with metabolic syndrome and that the association differs by 
gender and ethnicity (see Table 2.5). There were a total of 11,107 participants 25 years of 
age or older with 5,341 men and 5,766 women. The prevalence of metabolic syndrome in 
this sample was 29.9% (95% CI, 27.7 – 323) in men and 28.4% (95% CI, 26.2 – 30.8) in 
women.  
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Table 2.5 
 
Odds Ratio and Confidence Intervals for Education Level and Metabolic Syndrome Stratified by Covariant in NHANES III 
Women            Years of Education 
          < 12 Years           12 Years       > 12 Years 
          n=2166            n=1941          n=1659 
Ethnicity Model Adjustment OR 95% CI OR 95% CI OR 
Age, ethnicity 2.25 1.74-2.91 1.67 1.31-2.12 1.0 
Age, ethnicity, health behaviors 1.85 1.42-2.41 1.54 1.21-1.97 1.0 
 
 
All 
Age, ethnicity, health behaviors, parity 1.77 1.39-2.24 1.46 1.16-1.84 1.0 
White 
n=718, 1012, 952 
Age, ethnicity, health behaviors, parity 1.68 1.26-2.23 1.35 1.03-1.77 1.0 
Black 
n=504, 553, 440 
Age, ethnicity, health behaviors, parity 1.10 0.68-1.78 1.42 1.06-1.90 1.0 
Mexican-American 
n=849, 323, 186 
Age, ethnicity, health behaviors, parity 1.66 1.04-2.64 1.36 0.95-1.94 1.0 
Men          n=2276   n=1440         n=1659 
Age, ethnicity 1.33 1.04-1.70 1.40 1.13-1.77 1.0  
All 
Age, ethnicity, health behaviors 1.27 0.97-1.66 1.32 1.04-1.68 1.0 
White 
n=738, 700, 979 
Age, ethnicity, health behaviors 1.20 0.87-1.66 1.37 1.04-1.68 1.0 
Black 
n=515, 423, 322 
Age, ethnicity, health behaviors 1.01 0.63-1.62 1.02 0.69-1.51 1.0 
Mexican-American 
n =52, 274, 250 
Age, ethnicity, health behaviors 0.75 0.54-1.05 0.87 0.53-1.45 1.0 
Note. Health behaviors alcohol consumption, smoking, physical activity, and diet: 
From: “Socioeconomic disparities in metabolic syndrome differ by gender: Evidence from NHANES III,” E. Loucks, D. Rehkopf, C. 
Thurston, & I. Kawachi, (2007). Annals of Epidemiology, 17, 23. 
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 Less than 12 years of education was statistically significantly associated with an 
increased risk of metabolic syndrome in both men (OR 1.33;95 % CI 1.04 – 1.70) and 
women (OR 2.25; 95 % CI 1.74 – 2.91) (Loucks et al., 2006). When adjusted for health 
behaviors (dietary consumption of total fat, carbohydrates, fiber, physical activity, 
smoking, and alcohol consumption) the relationship remained significant for women but 
not for men.  
 Santos, Ebrahim, and Barros (2008) found similar results when investigating 
socio-economic and gender status and metabolic syndrome in adults in Porto, Portugal. 
There were 1962 participants aged 40 or older (1207 women and 755 men). The 
prevalence of metabolic syndrome in the study population was 22.0% using ATP III 
criteria and 31.8% when IDF criteria were applied. They found that metabolic syndrome 
was more prevalent in women verses men using both definitions, All five of the 
diagnostic criteria were present in 3.1% of the women and 0.6% of the men. The odds of 
metabolic syndrome in women increased with age and decreased with education level and 
social class. In men metabolic syndrome was not associated with any socio-economic 
indicators. The researchers hypothesized that an unfavorable socio-economic 
environment increases the risk of metabolic syndrome in a gender-specific manner and 
that men in lower socio-economic strata are more likely to have more physically 
demanding occupations which would increase their total caloric expenditure (Santos et 
al., 2008). This would be a protective mechanism for men that would prevent them from 
developing metabolic syndrome. 
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Nonpharmacologic Measures for Treatment of Metabolic Syndrome   
 Lifestyle modification is a primary treatment modality for all of the parameters 
that make up metabolic syndrome. Such modifications include changes in both dietary 
and exercise behaviors.  
Diet. Food consumption patterns may be related to socioeconomic status (Loucks 
et al., 2008). Energy dense foods are predominantly composed of sugars, fats, or refined 
grains are cheaper and individuals with low incomes may preferentially purchase these 
foods resulting in a higher caloric intake and increased risk of obesity. Simple changes in 
diet may decrease the incidence of metabolic syndrome. The Mediterranean style diet has 
been discussed as one way to facilitate a healthier life style.  
The Mediterranean style diet consists of a large amount of plant foods (i.e. fruits, 
vegetables, nuts, and beans), minimal amounts of processed foods, fresh fruit as a desert 
rather than concentrated sugars, low to moderated amounts of dairy products (i.e. yogurt 
and cheese), less than four eggs per week, low amounts of red meat, and wine with meals 
in a low to moderated amount (Serra-Majem, Roman, & Estruch, 2006). There is, in 
general, a higher incidence of cardiovascular disease in the United States and northern 
European countries when compared with countries of the Mediterranean basin (France, 
Spain, Greece, and Italy). This difference in incidence has led to investigation of the 
association of diet to cardiovascular disease.  
Serra-Majem et al. (2006) identified 55 clinical trials investigating this 
relationship, of which 12 were excluded due to language, the fact that the intervention 
was limited to one food product, or for methodological weaknesses, leaving 43 studies 
for the systematic review. The authors identified weaknesses in the review of the 
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evidence on the use of the Mediterranean style diet. The evidence is derived primarily 
from observational studies, personal reviews, and several studies were excluded from 
previous reviews of the Mediterranean style diet (Serra-Majem et al., 2006). These 
excluded studies were critical of, or did not support the use of, Mediterranean style diet 
raising the possibility of bias in the other analysis. In their opinion several of the 
excluded studies were well conducted and their outcomes valid.  
 Belahsen and Rguibi (2006) found that there is increasing evidence that lifestyle 
changes which incorporate a decrease in activity, an increase in caloric intake, and 
adopting a more western style diet may be contributing to the increase in obesity and 
diabetes in southern Mediterranean countries. They postulate that by the year 2020 71% 
of ischemic heart disease deaths, 75% of stroke deaths, and 70% of diabetes related 
deaths will occur in developing countries.  
 Belahsen and Rguibi (2006) determined that an increase in cardiovascular risk 
factors and rates of obesity in this area is linked to an increasingly sedentary way of life. 
There has been a decrease in physical activity and leisure time is spent watching more 
hours of TV per week. There is also a corresponding increase in the utilization of vehicles 
and activity saving appliances. The Jordan Global School-Based Student Health Survey 
showed that 44.6% of men and 45.2% of women did not walk or ride a bike. A study in 
2002 among Moroccan women over 15 years of age found that physical inactivity 
appeared to play a crucial role in the development of body fat and may be a risk factor for 
development of metabolic syndrome (Belahsen & Rguibi, 2006).  
 There has been significant progress in raising food consumption per person and 
this increased availability of food has created a shift in what had been the standard diet in 
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this area of the Mediterranean. This shift in diet has created away from barley as the 
primary grain source and an increased consumption of wheat and livestock products. 
There is also a shift towards the use of vegetable oils for a dietary fat source. Belahsen 
and Rguibi (2006) believe that the “important point is that there has been a remarkable 
increase in the intake of dietary fats” (p. 1133). There has also been an approximately 
1000 kcal per captia per day increase from 1965 – 2000, which exceeds the per caput 
energy requirements.  
 This shift from the traditional Mediterranean style diet to a more western 
industrialized diet and a more sedentary life style could explain the increases in obesity 
seen in this region (see Table 2.6). A move from a more rural to urban population has 
also been accompanied by an increase in obesity, hypertension, diabetes, and 
hypercholesterolaemia (Belahsen & Rguibi, 2006).   
 The Mediterranean dietary pattern emphasizes that fat consumption should be 
between 30 and 40% of an individual’s daily energy intake (Giugliano & Esposito, 2008). 
These fats should primarily come from monounsaturated fatty acids. There is not a single 
Mediterranean style diet as the dietary habits vary from country to country, but the 
primary characteristics of this dietary style include large amounts of plant food, olive oil 
as the principle source of dietary fat, fish and poultry in moderation, little red meat, and a 
moderate amount of alcohol usually with meals in the form of wine.  
 In a review of the European Prospective Investigation into Cancer and Nutrition 
(EPIC) study of 17,238 women and 10,589 men who were not obese at baseline, 
individuals with a high adherence to Mediterranean style diet had a significantly lower 
risk of being obese (OR 0.69, 95% CI 0.54-0.89 for women; OR 0.68, CI 0.53-0.89 for 
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men) (Giugliano & Esposito, 2008). When a high consumption of olive oil (46g/day) was 
compared with a lower consumption (6g/day) there was no association with increased 
weight. An inverse relationship was also observed between adherence to the 
Mediterranean style diet and increases in insulin resistance. Additionally, a cross-
sectional analysis of 2,834 individuals in the Framingham Offspring Study showed that 
whole grain and cereal fiber intakes were associated with a 38% lower risk of 
development of metabolic syndrome (Giugliano & Esposito, 2008). 
Table 2.6 
 
Calorie Consumption and Obesity in Southern Mediterranean Countries 
Energy Consumption Male Obesity % Female Obesity % 
Country 
1965-1967 2000-2002 2002 2005 2002 2005 
Algeria 1740 2990 4.52 5.18 11.91 13.44 
Egypt 2287 3318 21.98 21.98 39.34 45.46 
Jordan 2152 2834 19.62 19.62 40.19 35.62 
Libya 2061 3324 10.74 11.45 21.13 22.52 
Tunisia 2323 3272 7.74 7.74 28.78 30.2 
Note. Energy consumption in kcal per capita per day; obesity = BMI > 30 kgm-2
From: “Population health and Mediterranean diet in southern Mediterranean countries,” 
R. Belahsen, & M. Rguibi, (2006). Public Health Nutrition, 9, 1133. 
 
 The Seventh Report of the Joint National Committee on Prevention, Detection, 
Evaluation, and Treatment of High Blood Pressure (JNC 7) recommends lifestyle 
modification by all individuals and adopting healthy lifestyles (USDHHS, 2003). 
Lifestyle modification is an indispensable part of the management of those with 
hypertension.  In individuals who are overweight or obese major lifestyle modifications 
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have been shown to be effective in reducing blood pressure (USDHHS, 2003). The JNC 7 
also recommends the use of Dietary Approaches to Stop Hypertension (DASH) eating 
plan (USDHHS, 2003). The DASH diet is rich in potassium and calcium, but 
recommends a restriction on dietary sodium, an increase in physical activity, and 
moderate alcohol consumption. The lifestyle modifications that reduce BP also enhance 
antihypertensive drug efficacy and this synergistic approach decreases cardiovascular 
risk. A 1,600 mg sodium DASH diet plan has similar outcomes in blood pressure 
reduction to single drug therapy. When combinations of two or more lifestyle 
modifications are initiated they can achieve even more blood pressure reduction 
(USDHHS, 2003). 
 Exercise. Another risk factor for metabolic syndrome that is suitable for 
intervention in individuals in all socioeconomic circumstance is exercise. Carroll and 
Dudfield (2004) performed a review of literature to determine the effects of exercise on 
the metabolic syndrome, insulin resistance, abdominal adipose tissue accumulation, 
impaired glucose regulation, atherogenic dyslipidemia, and hypertension.  
Nine months of exercise training alone increases maximal aerobic capacity by 
14% in obese middle-aged and older men without a significant change in bodyweight, 
oral glucose tolerance response, lipids, or blood pressure. Hypocaloric diets and body 
weight reduction also improve insulin resistance. When dietary changes or exercise 
induce an 8% weight loss, insulin sensitivity improves up to 60% (Carroll & Dudfield, 
2004). 
A regular exercise program conducted three to five times a week for 30 to 60 
minutes at lower intensity than what is typical for cardiovascular fitness has shown 
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metabolic benefits (Carroll & Dudfield, 2004). Aerobic exercise and dietary studies 
found that exercise lowers blood pressure and improves glucose metabolism in obese, 
sedentary insulin-resistant men. This intervention reduced body fat by 21% and produced 
a 9% overall reduction in weight (Carroll & Dudfield, 2004). In sedentary overweight 
European and South Asian males and females exercise training consisting of three half-
hour sessions of walking or jogging and one supervised aerobic circuit training session 
produced no weight change, but insulin sensitivity was improved by 40% (Carroll & 
Dudfield, 2004). 
 When blood glucose levels are higher than normal, but less than a diagnostic level 
for diabetes it is referred to as impaired glucose regulation. Carroll and Dudfield, (2004), 
reviewed the 1999 Obesity Education Initiative expert panel. This panel reviewed five 
RCTs that showed weight loss produced by lifestyle intervention improved fasting 
glucose levels when compared to controls. They reviewed three additional RCTs which 
were conducted in various countries with various ethnic groups. The review of these 
RCTs confirmed that regular exercise can prevent or delay the onset of type II diabetes in 
high risk groups who suffer from impaired fasting glucose.  
 Individuals with low levels of HDL cholesterol, hypertriglyceridemia, and a high 
level of small dense low density lipoprotein (LDL) have athrogenic dyslipidemia. This 
cluster of dyslipidemic markers has been associated with increases in CVD. The literature 
search revealed 65 RCTs investigating exercise and lipoprotein-lipids. Only 15 of the 
original 65 articles were analyzed (Carroll & Dudfield, 2004). The 15 clinical trials 
incorporated 20 study groups. Ten study groups were composed of male only 
participants, six groups were mixed male and female, and 4 groups were female only. 
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There were 1007 total participants with 587 randomized to the exercise intervention 
groups and 420 to control groups. The duration of the exercise interventions ranged from 
12 to 52 weeks with a median of 39 weeks. Exercise frequency was three to five times a 
week with the duration being 30 to 60 minutes. 
 Body mass changes were reported in 12 of the 20 treatment groups and three 
others reported changes in BMI (Carroll & Dudfield, 2004).  The mean changes in body 
mass in the exercise study groups ranged from between 1.5 and 1.9 kg; except that the 
single 12 month program produced a 4.0 kg change. All 20 study groups examined HDL-
C response to exercise training alone compared with a control group with no exercise. 
HDL-C analysis showed an increase of 0.046 mmol/L (95% CI 0.27 – 0.65mmol/L, 
p<0.0001) (Carroll & Dudfield, 2004). Triglycerides were evaluated in 19 of the 20 
groups. There was a mean reduction of triglycerides of -0.21 mmol/L (95% CI of -0.29 to 
-0.14, p<0.0001) (Carroll & Dudfield, 2004). The results of this analysis revealed that 
moderate to moderately vigorous regular supervised exercise training is associated with 
modest improvements in HDL and TG levels in a middle-age and older overweight or 
obese adults (see Table 2.7).  
 Hypertension is a well established metabolic disorder and approximately 25 to 
33% of normal weight hypertensive individuals also suffer from insulin resistance. A 
three to nine percent reduction in weight is associated with a mean reduction of systolic 
and diastolic blood pressure of approximately 3.0mm Hg. Exercise training reduces blood 
pressure in approximately 75 – 85% of the groups with a weighted mean reduction of 
10.6/8.2 mm Hg.  These blood pressure reductions were noted as early as 10 weeks after 
commencement of the exercise program. (Carroll & Dudfield, 2004). 
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Table 2.7 
 
Effect Size of Exercise on Lipoprotein Levels in Overweight/Obese Sedentary Men and 
Women 
Standardized mean difference 
method 
Weighted mean difference method Lipoprotein 
Particle Type 
Effect 
Size 
95% CI p-value Effect 
Size 
95% CI p-value 
Total 
Cholesterol 
-0.05 -0.178, 
0.08 
0.50 -0.05 -0.14, 
0.04 
0.29 
LDL-C 0.001 -0.116, 
0.12 
0.98 0.005 -0.07, 
0.06 
0.89 
HDL-C 0.254 0.14, 
0.37 
<0.0001 0.046 0.27, 
0.065 
<0.0001 
Triglycerides -0.326 -0.46, -
0.21 
<0.0001 -0.21 -0.286, -
0.14 
<0.0001 
From: “What is the relationship between exercise and metabolic abnormalities?”S 
Carroll, & M. Dudfield, (2004). Sports Medicine, 34, 339 
 
 This chapter has been a review of literature on the prevalence and cost of 
cardiovascular disease in the United States and the cause and effect relationship of 
metabolic syndrome and cardiovascular disease. The effect of socioeconomic position 
has on the prevalence of metabolic syndrome was reviewed, as well as the 
nonpharmacologic measures that can be employed to combat metabolic syndrome. 
23 
 
 
 
Chapter Three: Methodology   
 This chapter includes a description of the design, setting and sample for the 
project and the methods and procedures for the study. This is followed by a discussion of 
the feasibility, data analysis plan and protection of human subjects.   
Study Design 
This project was the implementation of an evidence-based practice change 
incorporating an intensive dietary and exercise program for patients with metabolic 
syndrome and evaluation of the effect of that change on lipoproteins HDL-C and 
triglycerides, serum glucose levels, blood pressure, and waist circumference. This study 
was a one-group before-and-after design, with baseline data obtained on patients prior to 
the practice change. The study ran for six months. 
Setting and Sample 
 The setting for the study was an internal medicine practice in a large city in the 
Southeastern United States. The practice has one physician and one nurse practitioner. 
There are approximately 3,206 patients in this practice 20% of whom would meet the 
inclusion criteria.   
Criteria for inclusion in the study were: males and females ages 18 to 65 who met 
the ATP III diagnostic criteria for metabolic syndrome. Exclusion criteria were:  
individuals diagnosed with diabetes and those with, dietary limitations due to religious or 
medical conditions, or who were unable to perform the moderate exercise portion of the 
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study due to preexisting medical conditions. Participants, who were diagnosed with 
diabetes after the start of the study, were eligible to complete the study and be included in 
the final analysis.  
Procedures 
Participants were recruited for 30 days from the practice location. All patients 
who met the inclusion criteria were considered eligible for the study. Patients who had a 
current diagnosis of metabolic syndrome and who consented to be in the study were re-
evaluated by ATP III criteria and if they met the definition were eligible for participation. 
Other individuals who did not have a diagnosis of metabolic syndrome, but during the 
normal course of their appointments appeared to meet the criteria were evaluated by ATP 
III criteria and if diagnosed with metabolic syndrome they were given the option of 
participation during that office visit. Prior to agreeing to participate all individuals were 
counseled by the primary investigator regarding the diet and exercise programs. 
Practice change. A food consumption frequency analysis was performed on all 
patients entering the study. A food scoring system (FSS) was utilized to provide 
information on frequency of consumption of foods within specific food groups.  
Dietary counseling was provided to each participant at the time of the initial and 
each subsequent visit. The diet and exercise programs were furnished as an 
individualized folder/booklet. These booklets include exercise and dietary logs as well as 
other educational materials. Handouts/pamphlet on diet and exercise recipe booklet, 
sample shopping list, invitation to E-mail newsletter was provided at the initial meeting. 
The participants’ exercise and dietary logs were reviewed at the visits on day 30, day 90, 
and day180.  
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 The exercise recommendations were based on the data reviewed earlier as well as 
the recommendations of the American Heart Association and the US Department of 
Agriculture food guide pyramid. All study participants had their current exercise 
practices evaluated prior to beginning the study. Each participant was then counseled by 
the primary investigator on an unsupervised exercise program. Weight training was also 
encouraged. A written exercise program was provided to each participant at the initial 
visit in addition to the exercise log.  
Evaluation Plan 
Two medical assistants were trained in all aspects of data collection and they were 
the only individuals except the primary investigator and a master’s level dietetic intern to 
collect data. A complete history and physical examination was performed at the initial 
visit. The history included a review of social, demographic, personal, and family medical 
history including current dietary habits and physical activity, tobacco use, and alcohol 
intake. The physical exam consisted of a head-to-toe physical and included 
anthropometric measurements (height, weight and calculation of BMI), waist 
circumference, and blood pressure. Laboratory studies included lipoprotein and glucose 
levels.  
Subsequent visits occurred at 30, 90, and 180 days. Evaluation included updating 
the medical history, including smoking and alcohol intake; measuring lipoproteins, 
fasting blood glucose, blood pressure, waist circumference, anthropometrics; analysis of 
dietary and exercise logs; and individual counseling based on these measurements. 
 Anthropometric measurements. Anthropometrics were obtained at each visit with 
the participant in light clothing and barefoot. Body weight was measured to the nearest ¼ 
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pound as measured on a standard standing office scale. Height was measured at the initial 
visit to the nearest 1/8th inch using a stadiometer. BMI was calculated using a standard 
BMI chart.  
 Waist circumference. Waist circumference was measured at each visit with the 
subject standing erect with the clothing from around the waist removed. A flexible un-
stretchable tape was used, avoiding exertion of pressure on the tissue. The waist 
circumference was  measured midway between the lower limit of the rib cage and the 
iliac crest with the tape level and recorded to the nearest millimeter using the same tape 
measure at each visit. 
 Blood pressure. Blood pressure was measured at each visit using U.S. Department 
of Health and Human Services (JNC 7) (2003) guidelines. The ausculatory method with a 
properly calibrated and validated instrument was used to measure blood pressure. The 
subject was seated quietly for at least 5 minutes in a chair with both feet on the floor and 
the arm supported at the heart level. An appropriate sized cuff with the bladder encircling 
at least 80% of the arm was used. Two readings were taken at least five minutes apart and 
the average of the two readings were used unless there was a difference in the systolic 
blood pressure readings of more than 6 mmHg. If a third reading was necessary the 
average of the two closest readings was used. 
Lipoprotein levels. Fasting lipoprotein levels were measured at baseline, 90 days, 
and 180days. Lipoprotein levels (total cholesterol, triglyceride, HDL-C, and LDL-C) 
were evaluated using a Cholestech LDX Cholesterol Analyzer™. The reliability of the 
analyzer was established per the manufactures instructions using the Cholestech optics 
check and liquid controls. The optics check was conducted using the analyzer check 
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cassette supplied with the unit. The optics check was conducted at a minimum once each 
day before patient sampling, when the unit was moved, or when the unit was serviced. 
The liquid controls were conducted at the beginning of each visit and if a different lot 
number or new box of cassettes was opened. The blood sample required for this 
evaluation was collected by finger stick.  
Glucose. Fasting glucose levels were evaluated with an Accu-Chek Compact Plus 
capillary glucose meter. This glucometer does not require calibration. Coding is 
performed automatically when the test strip drum is placed in the glucometer. Control 
testing, with the provided control solution, was performed as a minimum when the test 
strip drum was replaced, if the meter was dropped, or if the control bottle symbol flashed 
on the meter display. This did not require a second finger stick, since there was ample 
blood from the finger stick performed for the lipoprotein analysis.    
Exercise analysis. An exercise analysis was performed on all patients entering the 
study. Each participant was then counseled by the primary investigator regarding the 
exercise component. Participants were provided with written information regarding 
exercise, an exercise log, encouraged to exercise at least three (ideally five) days per 
week at a moderate level and to record their exercise on the exercise log. Exercise was 
defined as additional time during the day separate from work or other normal daily 
activities. The exercise component was evaluated at each visit. The exercise logs were 
evaluated and exercise was categorized as none (0 days per week), minimal (1-2 days per 
week), moderate (3-4 days per week), or maximal (more than 4 days a week). Exercise 
was judged as compliant or noncompliant. Participants were judged to have been 
compliant with the exercise component if their exercise averaged more than 135 minutes 
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per week (45 minutes a day for a minimum of 3 days a week) and were compliant at least 
13 of the 25 weeks of the study.  
Dietary analysis. A food consumption analysis was performed on all patients 
entering the study using a food scoring system (FSS). Each participant was then be 
interviewed and counseled by the master’s level dietetic intern regarding the customized 
Mediterranean style diet. This customized plan was based on age, gender, weight, height, 
and physical activity and included suggested calories to be consumed each day, servings 
of grains, beans, vegetables, fruits, dairy products, healthy fats, and meats. Written 
information on the Mediterranean style diet was provided for each participant at the first 
visit along with the dietary log. At each visit the dietary logs and the FSS were reviewed 
to assess overall compliance as well as compliance within each food category/group. A 
nutrient analysis was not conducted. The FSS provided a baseline description of the 
participants’ diet and how it related to the recommended Mediterranean style diet. The 
same FSS was used throughout the study to measure change and compliance over time. 
The master’s level dietetic intern also evaluated the participants’ dietary changes as they 
relate to the participants’ perception of their progress. This was developed as a critique of 
the dietary portion of the project. A FFS was completed during the last visit and changes 
in dietary patterns were assessed in relation to the initial FFS. 
Practice Impact 
Current staff members were trained on and are proficient in the use of the 
materials to be used. A review of the material and the specific requirements of the study 
was conducted. Staff members were briefed on confidentiality and the study guidelines.  
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There was minimal fiscal impact on the practice setting. Initial participant 
interviews coincided with previously arrange office visits. Follow-up visits were 
conducted during non-office hours so as to not interfere with the operation of the clinic 
and no reimbursement from insurance companies was sought. The medical assistants 
agreed to participate without compensation for their time, but were reimbursed for fuel 
and a meal was provided. The total cost of intervention supplies per participant was 
estimated to be approximately $.0.15 per visit (see descriptions below). This cost was 
borne by the practice. The total cost of miscellaneous supplies, copying, binding, 
folders/booklets, and computer supplies did not exceed $300. During the implementation 
period, this cost was borne by the primary investigator.   
The Cholestech LDX Analyzer was available in the practice site and the cost of 
each use was approximately $12 per cassette per visit. The cassettes for the cholesterol 
analyzer are being donated by the Cholestech representative and purchased by the 
primary investigator out of a grant from the University of North Florida, School of 
Nursing. The cost of the one use lancing device is approximately $0.02 per patient per 
visit. Miscellaneous supplies (cotton balls, alcohol wipes, gauze) cost approximately 
$0.05 per participant per visit.  
A new Accu-Chek Compact Plus capillary glucose meter was supplied by the 
Accu-Chek representative at no cost. The cost of the test strips was approximately $0.95 
per strip. The Accu-Chek representative also supplied the test strip drums and control 
solution at no cost.  
 
 
30 
Protection of Human Subjects 
Prior to beginning recruitment of participants University of North Florida (UNF) 
Institutional Review Board (IRB) approval was obtained. All institutional, state, and 
federal regulations with respect to protection of human subjects were adhered too. If at 
any time possible injury either physical or psychological to a participant was suspected 
the action or inaction that could have caused the injury would have been immediately 
corrected. No actual injuries occurred. The procedures outlined by the UNF IRB would 
have been followed if required.  
Protection of participant information was of paramount importance. After closing 
recruitment participants were randomly assigned a study number and all collected data 
was only linked to the study number. Any documents that linked a participants name or 
other identifying data with their study number was maintained by the primary 
investigator in a secured area. Any documents that would link a participants name with 
their study number or other study data was destroyed as soon as possible after the study 
was closed. Data collectors and researchers, other than the primary investigator, did not 
have access to the raw data until the study was ended. 
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Chapter Four: Results 
 This chapter provides a description of the sample and the results of the analysis 
pertaining to outcomes. This is followed by a discussion of unintended consequences and 
barriers encountered. 
Subject Disposition 
 During the enrolment period fifteen (15) patients who met the inclusion criteria 
agreed to participate in the study. The first meeting (baseline) was conducted one week 
after the closing of the enrolment period. Twelve of the fifteen participants were present 
at the first meeting and had baseline biometric measurements taken. The attrition of 
participants continued throughout the study period. Ten of the participants who signed 
consents did not complete the study. Five of the ten withdrew for unknown reasons, three 
withdrew due to changing primary care physicians, and 2 withdrew due to the dietary 
constraints. Figure 4.1 shows the disposition of subjects during the study period.  
Sample 
 Five of the original fifteen participants completed the study. All were Caucasian, 
three of the five were male with the youngest being 47 and the oldest being 55. Two were 
female and their ages were 40 and 61. Table 4.1 shows the demographic information of 
the five individuals who completed the study. 
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Initial Consent Obtained N = 15 
Day 180 Evaluation N = 5 
3 Individuals were not present at the initial 
meeting. Reason Unknown. 
1 Participant withdrew, change primary care 
physicians. 
5 Participants withdrew, 2 withdrew 
consent due to dietary constraints, 2 
changed primary care physicians, and 1 
reason unknown. 
1 Participant withdrew reason unknown. 
Baseline Evaluation N = 12 
Day 30 Evaluation N = 11 
Day 90 Evaluation N = 6 
Figure 4.1. Disposition of Subjects 
 
Table 4.1 
Demographic Information for the Five Individuals Who Completed the Study 
Data Male Female 
Participant 3 2 
Average Age 52 50.5 
Current Tobacco Use 0 0 
Currently Taking Hypertension 
Medications 2 1 
Currently Taking Dyslipidemia 
Medications 2 1 
History of Heart Disease 0 0 
 
Metabolic Components 
The data as it relates to the five metabolic disorders that comprise metabolic 
syndrome (waist, glucose, blood pressure, HDL, and triglycerides) were only computed 
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for participants who completed the study (see Table 4.2). Biometric measurements were 
taken at baseline, day 30, day 90, and day 180 for waist, glucose, systolic blood pressure, 
and diastolic blood pressure. Biometrics for HDL and triglycerides were taken at 
baseline, day 90, and day 180. The data was analyzed using SPSS version 16.0. The 
mean, standard deviation and significance level were obtained for all metabolic syndrome 
components at baseline and were compared to day 180.  
Table 4.2 
Descriptive Statistics for Metabolic Syndrome Component at Baseline and Day 180  
Baseline Day 180 
Metabolic Syndrome 
Component Mean 
Standard 
Deviation 
Mean 
Standard 
Deviation 
Significanc
e 
Waist 120.90 24.79 115.10 22.86 p = 0.007 
Glucose 100.80 22.90  98.40 7.30 p = 0.828 
SBP 135.80 16.76 120.80 2.20 p = 0.108 
DBP 85.60 5.32 71.20 6.38 p = 0.047 
HDL 32.80 11.37 34.40 4.57 p = 0.327 
Triglycerides 207.60 75.02 216.00 124.42 p = 0.840 
Average Number 
Components Males 
3.67 0.58 3.00 1.41  
Average Number 
Components Females 
4.00 1.41 4.00 1.41  
* 95% Confidence Level and α 0.05  
 Waist. The average decrease in waist size from baseline to day 180 (5.8 cm ± 2.6 
cm) was evaluated using paired t-test. There was a statistically significant change at the 
95% confidence interval (p = 0.007) (see Figure 4.2). 
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Figure 4.2. Average Waist Size of Participants from Baseline to Day 180 
 
Glucose. The average decrease in glucose from baseline to day 180 (2.4 mg/dl ± 
15.6 mg/dl) was evaluated using paired t-test. There was a non-statistically significant 
change at the 95% confidence interval (p = 0.828) (see figure 4.3). 
 
 
Figure 4.3. Average Glucose of Participants from Baseline to Day 180 
 
Systolic Blood Pressure (SBP). The average decrease in SBP from baseline to day 
180 (15.0 mmHg ± 11.78 mmHg) was evaluated using paired t-test. There was a non-
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statistically significant decrease in SBP at the 95% confidence interval (p = 0.108) (see 
figure 4.4). 
 
Figure 4.4. Average Systolic Blood Pressure of Participants from Baseline to Day 180 
Diastolic Blood Pressure (DBP). The average decrease in DBP from baseline to 
day 180 (14.4 mmHg ±  1.06 mmHg) was evaluated using paired t-test. There was a 
statistically significant decrease in DBP at the 95% confidence interval (p = 0.047) (see 
figure 4.5).  
 
Figure 4.5. Average Diastolic Blood Pressure of Participants from Baseline to Day 180 
 
 High Density Lipoprotein (HDL). The average increase in HDL from baseline to 
day 180 (1.6 mg/dl  ±  1.16 mg/dl) was evaluated using paired t-test. There was a non-
statistically significant increase of HDL at the 95% confidence interval (p = 0.327) (see 
figure 4.6). 
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Figure 4.6. Average HDL Levels of Participants from Baseline to Day 180 
 
 Triglycerides. The average increase in triglycerides from baseline to day 180 (8.4 
mg/dl  ±  49.39 mg/dl) was evaluated using paired t-test. There was a non-statistically 
significant increase of triglycerides at the 95% confidence interval (p = 0.084) (see figure 
4.7). 
 
Figure 4.7. Average Triglyceride Levels of Participants from Baseline to Day 180 
Exercise and Diet 
 Exercise. The exercise segment of the intervention was evaluated on a compliant 
noncompliant basis. As previously stated the participants were encouraged to exercise at 
least three (ideally five) days per week at a moderate level and to record their exercise 
time on the exercise log. Exercise was defined as additional time during the day separate 
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from work or other normal daily activities. Appendix E contains the exercise handout 
given to participants. 
 For the purposes of this study participants were judged to have been compliant 
with the exercise portion of the intervention if their average exercise minutes during a 
week were greater than or equal to 135 minutes (45 minutes per day for 3 days). Weekly 
minutes were totaled for the time period and the average for the time period their 
determined their compliance for that time period (baseline to day 30, day 31 to day 90, 
day 91 to day 180). The participant was determined to compliant overall if they were 
compliant for two (2) of the three (3) periods evaluated. Table 4.3 shows the exercise 
compliance for each participant at day 30, day 90, day 180, and their overall compliance 
rating. Eighty percent (80%) of the participants were compliant with the exercise portion 
of the intervention. The compliance average ranged from a high of 337.69 minutes (60 
minutes a day for 5.6 days a week) per time period to a low of 144.23 minutes (45 
minutes a day for 3.2 days a week) per time period. 
 Diet. The dietary segment of the intervention was also evaluated on a compliant 
noncompliant basis. The participants were encouraged to modify their current dietary 
practices to coincide with the recommended servings for specific food groups (see 
appendix F).  
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Table 4.3 
Average Minutes Exercised by Participant, Time Period, and Overall Rating 
Participant  Day 30 Day 90 Day 180 Average Minutes 
Overall 
Rating 
4 78.75 140.63 67.31 95.56 Noncompliant 
6 206.25 226.25 144.62 192.37 Compliant 
8 183.75 101.25 147.69 144.23 Compliant 
9 315 301.88 293.08 303.32 Compliant 
14 333.75 341.25 338.08 337.69 Compliant 
 
 To evaluate compliance the recommended daily servings were averaged for each 
week. If the recommended daily servings for the week was greater than or equal to the 
recommended servings the participant was judged to be compliant for that food group. If 
the number of compliant food groups for the week was greater than or equal to the 
number of noncompliant food groups then the participant was judged to be compliant 
with the dietary component for that week. If the weeks of compliance for the time period 
(baseline to day 30, day 31 to day 90, day 91 to day 180) were greater than or equal to the 
number of weeks of noncompliance then the participant was judged to be compliant for 
that time period. If the participant was compliant for two of the three time periods they 
were judged to be compliant with the dietary portion of the intervention. Table 4.4 show 
the dietary compliance for each participant at day 30, day 90, day 180, and their overall 
compliance rating.  
 As can be observed in table 4.4 only one participant (20 percent) was compliant 
with the dietary portion of the intervention. This low level of compliance makes 
evaluation of the impact of dietary changes difficult. Table 4.5 demonstrates the average 
daily serving change for each participant by food groups. This difference was obtained by 
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comparing the daily average servings by food group for the first four weeks of the study 
and comparing them to the daily average servings by food group for the last four weeks 
of the study. This reason for this evaluation is to look for positive changes in eating 
habits of the 180 days of the study.  
 Participant 4 had overall the largest average change of dietary practices over the 
180 days of the study at 0.4608 servings. He increased his grains, vegetables, and 
nuts/seeds/legumes/beans by more than 1.5 servings a day and decreased his sweets and 
red meat.  
Table 4.4 
Dietary Compliance by Participant, Time Period, and Overall Rating 
Participant  Day 30 Day 90 Day 180 Overall Rating 
4 Compliant Compliant Compliant Compliant 
6 Noncompliant Noncompliant Noncompliant Noncompliant 
8 Noncompliant Noncompliant Noncompliant Noncompliant 
9 Noncompliant Noncompliant Noncompliant Noncompliant 
14 Noncompliant Noncompliant Noncompliant Noncompliant 
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Table 4.5 
Average Daily Serving Change for Each Participant by Food Group 
Food Group 
Participant 
4 Daily 
Average 
Change 
Participant 
6 Daily 
Average 
Change 
Participant 
8 Daily 
Average 
Change 
Participant 
9 Daily 
Average 
Change 
Participant 
14 Daily 
Average 
Change 
Grains 1.56 1.05 -0.10 2.58 0.19 
Vegetables 1.50 0.94 0.48 -0.08 -1.58 
Nuts/Seed/Legumes/
Beans 2.33 0.27 -0.20 -0.32 0.04 
Fruit 0.36 -0.71 -0.04 -0.96 0.54 
Olive Oil 0.32 -0.25 -0.07 0.93 0.14 
Cheese & Yogurt -0.19 -0.72 -0.28 0.58 0.53 
Red Wine -0.07 0.00 1.00 0.30 0.54 
Fish -0.28 -0.25 0.04 -2.46 0.14 
Poultry 0.16 0.35 -0.44 -1.79 -0.83 
Eggs 0.00 0.00 -0.13 -0.04 0.17 
Sweets -0.08 2.50 0.53 -0.79 -0.18 
Red Meat -0.08 0.61 0.24 -0.05 0.06 
Average Change 0.4608 0.3158 0.0858 -0.175 -0.02 
* Negative number indicates decrease in number of average daily servings. 
 This chapter is a review of the subjects and the results of the dietary and exercise 
interventions on the various metabolic components. The compliance of the subjects with 
the exercise and dietary interventions was also reviewed as well as the average overall 
changes in serving changes for the selected food groups from the first week of the study 
to the last week of the study.  
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Chapter Five: Discussion 
 This chapter provides a discussion of the project outcomes and issues that 
developed during the completion of the project. This is followed by a discussion of the 
limitations of the study as well as recommendations for future projects of this subject and 
for future research. 
Discussion 
 The purpose of this project was to identify the effects of an intensive dietary and 
exercise program on patients with metabolic syndrome. Specifically, the project was to 
examine the effects of the program on waist circumference, blood pressure, HDL 
cholesterol, triglycerides, and fasting glucose. By extension the desired outcome was to 
move patients from a prothrombotic metabolic syndrome state to a less prothrombotic 
non-metabolic syndrome state. None of the five participants who completed the study 
moved to the non-metabolic state. All but one participant were compliant with the 
exercise portion. Interestingly, this person was the only one who was compliant with the 
dietary portion of the intervention. 
 The evidence suggests that diet and exercise programs are effective in controlling 
the components of metabolic syndrome. But, as with this study, the complexity of dietary 
and exercise interventions are complex impede adherence, both in execution and 
evaluation. These types of interventions require significant lifestyle changes and if they 
are to be successful the participants must exhibit concerted long term effort. 
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Limitations and Challenges  
 There were multiple challenges in this project. These include issues related to the 
sample, the metabolic components, adherence to the intervention, and even the selection 
of participants. 
 Sample. The final sample size was five participants (three male and two female). 
This small sample size at the completion of the study precludes dynamic statistical 
evaluation. Future projects of this type should begin with a more robust initial sample 
size. If possible a beginning sample size of at least 100 participants would be more 
appropriate. With an expected attrition of approximately 50% there would be a more 
realistic approximation of a normal distribution.  
 This increased number of participants would increase the complexity of the 
logistics and record keeping. Multiple meeting days and times may be necessary to 
accommodate the participants and their individual needs. A meeting area large enough to 
accommodate the maximum number of participants would be required and since the 
biometrics are taken in a fasting state a greater amount of appropriate foods would be 
required for participant consumption at each meeting. Increasing the number of 
participants would also increase the cost of the study and funding would need to be 
addressed at an early stage. A specific data entry individual would be required if there 
were an increased number of participants. The primary investigator would have a difficult 
time performing as data entry, coordinator, and exercise counselor. It would also be 
desirable to have input from a statistician at a very early stage to assist with set up of 
Excel and SPSS type programs prior to beginning of data collection. 
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 Metabolic components. The small sample size (n=5) did not lend itself to strong 
statistical evidence of change in the metabolic components. However, the small sample 
size did not preclude the outcome of a statistically significant decrease in waist size. 
Although not statistically significant, systolic blood pressure and high density lipoprotein 
(HDL) trended in the desired direction (down for SBP and up for HDL). An increase in 
the number of participants or a lengthening of the study period (preferably both) may 
have produced more dynamic changes in these metabolic components. In contrast, the 
glucose and triglycerides averages were trending upward. Again the sample size was too 
small to hypothesis with any degree of certainty the possible explanation.  
 The overall compliance with the exercise regimen may account for some of the 
improvement in waist size, blood pressure, and HDLs. The literature from Carroll and 
Dudfield (2004) and my own anecdotal clinical experience, indicates that waist size, 
blood pressure, and HDL are affected more by exercise rather than diet, while glucose 
and triglycerides seem to be less affected by exercise. This is an important aspect for 
future research.  
 Diet and exercise. The exercise portion of the intervention was the easier of the 
two to track and had a significantly higher adherence rate when compared to diet. One 
possible explanation is that exercise is a finite time commitment during the day while 
dietary changes are necessary throughout the day and are therefore more difficult to 
maintain and track. Another difference that adds to the complexity of diet as compared to 
exercise is that there are 12 components to the dietary intervention and one component to 
the exercise component. An addition to the data collection should have been to establish 
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pre-study levels of exercise and compare them to post-study levels of exercise. This could 
have shown if there was a change in life style with reference to exercise. 
 As would be expected the dietary portion of the intervention was more 
complicated and time consuming for the participants. This is inherent in any dietary 
intervention that is designed to significantly change dietary lifestyle. Another difficulty 
with the dietary portion was overcoming the cultural differences in the diet. The 
Mediterranean style of eating is vastly different from the typical southeastern United 
States diet. This difference could have been blunted by limiting the number of food 
groups evaluated. The dietary portion also presented several barriers to change that had 
not been addressed in the initial planning of the study. The participants did not accept the 
need for the changes in their diet, they preferred their current diets because of tradition, 
and many were set in their ways and did not truly wish to make dramatic changes in their 
habits.  
 Record keeping and meetings. Self reporting has inherent problems one of which 
is the constant possibility of inaccurate information being submitted. It is difficult to 
judge the accuracy of entries in self reporting type data. Some reasons for this possible 
inaccuracy include the participant wanting to appear to be compliant in order to be 
praised by the researchers. They may also know and or like the researcher, they might 
feel that a greater appearance of compliance may help the researcher. These biases would 
be difficult if not impossible to overcome without making the collection process much 
more complicated. If the collection process were more complicated the researchers would 
run the risk of decreasing participation. 
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 Meeting at 90 and 180 days decreased the number of data points and made it 
difficult to note small incremental changes. Monthly meetings would have had several 
positive impacts. This increased frequency of meetings would have made it possible to 
intervene with counseling earlier and would have reinforced good changes and allowed 
for changing non helpful changes prior to them being made permanent. Monthly 
meetings would also have allowed for identifying individual barriers to diet and exercise 
as well as the opportunity to overcome the barriers. Having monthly meetings would 
have increased the number of data points, but would have also increased the scheduling 
problems for participants which could have increased the dropout rate. As previously 
mentioned an increase in the number of meetings would also have increased the monetary 
cost of the project. 
Selection of participants. It is difficult to gage the success of the interventions if 
the participant is currently taking medications for hypertension or dyslipidemia. It may be 
construed as unethical to expose participants to the increased risk of end organ damage 
and adverse events by stopping their existing medications. Ideally the target population 
for this type of intervention would be individuals who meet the diagnostic criteria for 
metabolic syndrome, but have not been placed on medication. This early intervention is 
possible by selectively targeting individuals with metabolic syndrome who are 
medication naive. 
Implications for Future Research 
 Future research at the practice level should target dietary changes of five food 
groups rather than the 12 in this study. The food groups to target would be increase olive 
oil, fish/chicken, and whole grains, as well as decrease concentrated sweets and red 
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meats. This less intensive intervention would allow the participants to make less extreme 
dietary changes and would be less of a challenge to the southern culture of food choices. 
Since the changes would be less extreme the complexity of participant record keeping 
would be decreased and could thereby increase adherence.  
 Future research at the practice level targeting exercise changes should 
differentiate the changes that take place with different types of moderate exercise as well 
as between age groups, and genders. This would allow more precise targeting of exercise 
interventions by types of exercises, age group, and gender. 
Implications for Practice 
 The research undertaken for this project has clarified dietary and exercise advice 
given to patient with metabolic syndrome. The dietary suggestions to increase olive oil, 
fish/chicken, and whole grains and decrease concentrated sweets and red have been 
incorporated into the standards of care at my practice setting. Dietary and exercise 
interventions have been incorporated into suggested lifestyle changes for pre-metabolic 
syndrome patients as well as metabolic syndrome patients. 
 If these dietary and exercise changes can be implemented prior to an actual 
diagnosis of metabolic syndrome it would, in all likely hood, decrease the incidence of 
metabolic syndrome and thereby decrease the prevalence of heart disease and diabetes. 
Conclusion 
 Metabolic syndrome continues to be a serious health problem in the United States. 
The presence of metabolic syndrome significantly increases the risk of developing type II 
diabetes and cardiovascular disease by producing a prothrombic state. The independent 
risk factors that create this prothrombic state increases the risk of micro and macro 
 
 If early intervention would decrease only systolic blood pressure by 12 – 13 
mmHg over 4 years a corresponding decrease of 21% in coronary heart disease, a 
decrease of 37% in stroke, and a decrease of 25% in cardiovascular deaths could be 
expected(USDHHS, 2005). This decrease in coronary heart disease, stroke, and 
cardiovascular death would translate in to billions of dollars save in health care 
expenditures. 
 This study even with a small sample size showed that waist size, systolic blood 
pressure, diastolic blood pressure, and high density lipoprotein levels were trending 
towards levels that would remove the patient from the diagnosis of metabolic syndrome. 
The largest benefit for the general population would result from intervention prior to a 
diagnosis of hypertension and diabetes. This would help decrease the cost of medical 
treatment and hospitalization.  
vascular changes and eventually to end organ damage. Dietary and exercise lifestyle 
changes are effective at changing this prothrombis state. The challenge is motivating the 
individuals to make the necessary lifestyle changes prior to end organ damage.  
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Appendix A. Review of the Evidence 
Author Type N Comments (Dates) 
Meta-analysis and systematic reviews 
36 studies, 172,573 
subjects 
Purpose was to assess the association between metabolic syndrome and 
cardiovascular events and death by reviewing longitudinal studies. 
Evidence suggested metabolic syndrome increased the risk of 
cardiovascular events and death. 
Gami et al. 
(2007) 
Meta-analysis and systematic 
review of longitudinal studies 
of metabolic syndrome and 
incidence of cardiovascular 
events and death. 
Mellen et al. 
(2006)
Meta-analysis of the effects of 
whole grain intake on 
cardiovascular disease 
7 studies, 285,376 
subjects 
Epidemiological cohort studies showing an inverse relationship 
between whole grain intake and CVD.  2.5 servings daily associated 
with a 21% decrease in risk of CVD.  229 post menopausal women 
study showed 6 or more servings per week was associated with a 40% 
decrease in coronary atherosclerotic progression. 
.
43 clinical 
trials,17031 subjects  
13 countries represented, conclusion that scientific evidence for 
Mediterranean Diet was observational and personal reviews. 24 of the 
43 studies included less than 60 subjects. Authors found that 
Mediterranean diet recommendations needed to be evidenced based and 
observational epidemiological studies were needed in the 
Mediterranean countries. 
Systematic review of 
outcomes of the use of the 
Mediterranean diet 
Serra-Majem  
et al.  
(2006) 
  
 
Dansinger  
et al. 
Meta-analysis on effect of 
dietary counseling for weight 
loss 
40 studies with 63 
treatment groups, 26 
with diet and 27 with 
diet and exercise 
RCTs comparing dietary counseling-based weight loss against usual 
care produced a mean net treatment effect of approximately 6% (5kg) 
of weight loss at 1 year. Modest weight loss reduces cardiovascular risk 
factors hyperglycemia, hypertension, & hypercholesterolemia. Modest 
weight loss through dietary and lifestyle counseling reduces risk of 
development of diabetes in glucose-intolerant individuals. 
(2007) 
All studies with a minimum of 1 year of follow-up, dependent variable 
weight-loss in treatment verses control arm. Treatments included 
exercise alone, diet alone, diet & exercise, meal replacements, very-
low-energy diet, orlistat, sibutramine, and advice alone. Interventions of 
diet alone, diet and exercise, and meal replacement decreased weight by 
5 – 9% at 6 months, then plateau with a 4.8 – 8% stabilization at 12 
Franz et al. Systematic review & meta-
analysis of weight-loss clinical 
trials with a minimum of 1 
year of follow-up 
80 studies included 
with 26,455 subjects 
enrolled and 
randomized and a 
overall attrition rated 
of 31% 
(2007) 
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Author Type N Comments (Dates) 
months and 3 – 4.3% reduction out to 48 months. Weight loss and 
maintenance for diet medications is similar to diet plus exercise at 6 
months, but a mean weight loss of 2 – 5% above exercise intervention 
is noted at 24 months. Very-low-energy diets resulted in dramatic 
weight loss followed by rapid and substantial weight gain. Exercise 
alone or advice did not result in successful weight loss, but no weight 
gain was noted. 
Reviews  
Epidemiology reviewed, prevalence of metabolic syndrome clustered 
by age groups reviewed, reviewed exercise recommendations, dietary 
recommendations, positive effects of exercise and dietary changes. 
Authors did not review inclusion criteria for articles. Validity of studies 
was not discussed. Possible relevant articles may have been overlooked 
although Table XI did give characteristics of methodology of RCTs 
evaluated. 30 to 60 min exercise 3 – 5 times a week at 40 – 60% VO2 
max shows positive outcome with reducing metabolic syndrome. 
Carroll & 
Dudfield 
Review of the relationship 
between exercise, diet and 
metabolic syndrome. 
20 male prevalence 
studies, 93111 
subjects; 15 female 
prevalence studies, 
64973 subjects; 6 
cross-sectional & 1 
prospective studies, 
22521 subjects; 3 
IGT RCTs studies, 
4333 subjects; 15 
exercise RCTs, 1017 
subjects;  
(2004) 
Giugliano 
& Esposito, 
(2008) 
Review of Studies N/A Review of studies involving Mediterranean diet and obesity, 
cardiometabolic risk, diabetes, metabolic syndrome as well as the 
possible protective mechanism of Mediterranean diet. 
Johnson & 
Weinstock 
Review for Clinicians N/A Review of the three diagnostic criteria for metabolic syndrome, review 
of controversies around the differences in the diagnostic criteria. 
Metabolic syndrome is an indicatory of long-term cardiovascular risk 
and Framingham is superior for short term risk assessment for 
cardiovascular risk. ADA and EASD question the clinical value of 
metabolic syndrome. Discusses flaws with ATP III criteria.  
(2006) 
Kaplan, & 
Keil, 
Review Literature N/A Review of literature with reference to CVD risk factors and 
socioeconomic status and the factors related to socioeconomic status. 
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Author Type N Comments (Dates) 
(1993) Discusses measurement of socioeconomic status/social class most 
common being education level, income, occupation, employment 
status, indexes of social class, measures of living conditions, are-based 
measures, life span measures, measures of income inequality. Reviews 
all cause mortality and CV mortality by SES. Risk factors of CV 
disease discussed and compared by SES. Questions if SES is an 
independent risk factor for CV disease. 
The Mediterranean-type diet lowered BMI, total, LDL- and 
triglyceride, insulinemia, and glycemia. Mediterranean-style diet 
promoted beneficial changes for fasting glucose, systolic blood 
pressure, the cholesterol/HDL cholesterol ratio. Mediterranean style 
diet was compared with low fat low cholesterol diet and Mediterranean 
proved more beneficial. 
Larion, 
Denis 
Review of Studies; Primary & 
Secondary Prevention,  
Primary Prevention 4 
studies N=1123, 
Secondary Prevention 
2 studies N=11928 
(2007) 
Guidelines 
Armstrong, Practice Guidelines N/A Primary goal to reduce risk for CVD, first line therapy related to major 
risk factors (elevated LDL, HTN, DM), Metabolic syndrome rarely 
manifests in the absence of obesity and physical inactivity. Clinical 
management goals reviewed for abdominal obesity, physical activity, 
diet, dyslipidemia, elevated blood pressure, prothrombic and 
proinflammatory states, and elevated fasting glucose 
(2006) 
Clinical Guidelines N/A Guidelines for management of HTN. The ultimate goal of therapy is to 
reduce cardiovascular & renal morbidity & mortality. A healthy 
lifestyle by all persons is critical for the prevention of HTN & is 
essential part of the management of those with HTN. Major lifestyle 
modifications are shown to lower BP (weight reduction in overweight 
or obese, adoption of the Dietary Approaches to Stop Hypertension 
(DASH) eating plan which is rich in potassium and calcium, dietary 
sodium reduction, physical activity, & moderation of alcohol 
consumption. 
U.S. 
Depatemtnet 
of Health 
and Human 
Services 
JNC-7 
(2003) 
 
American 
Diabetes 
Clinical Guidelines N/A National guidelines for diagnosis and management of diabetes. 
Hperglycemia insufficient to be diagnosed as diabetes is referred to as Standards of medical care in 
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Author Type N Comments (Dates) 
Association diabetes. as either IFG or impaired glucose tolerance (IGT), depending on 
whether it is identified through an FPG or an OGTT: ● IFG FPG 100 
mg/dl (5.6 mmol/l) to 125 mg/dl (6.9 mmol/l), ● IGT 2-h plasma 
glucose 140 mg/dl (7.8 mmol/l) to 199 mg/dl (11.0 mmol/l) 
(2007) 
Recently, IFG and IGT have been officially termed pre-diabetes. Both 
categories, 
IFG and IGT, are risk factors for future diabetes and cardiovascular 
disease. 
National 
Institutes of 
Health, ATP 
III, 
Clinical Guidelines N/A ATP III guidelines for lowering cholesterol and establishing criteria for 
metabolic syndrome. Therapeutic life style changes recommended. 
Dietary recommendations included. 
(2001) 
Studies 
Simons, Longitudinal cohort study 2085 60 years old or older followed for 16 years; Duppo New South Wales; 
main outcome measures CHD events, ischemic stroke, total mortality.  
Results metabolic syndrome increased risk in older individuals for 
CHD events, stroke events, and total mortality greater than general 
population of same age. 
et al., 
(2007) 
Lorenzo,  Longitudinal cohort study 2646 Ages 25 - 64 with 7.4 years of follow-up; conclusion metabolic 
syndrome is associated with a significant increase risk of CVD 
especially in men older than 45 & women older than 55. Metabolic 
syndrome increases CVD risk in people who are free of CVD or DM. 
CVD risk prediction by metabolic syndrome is inferior compared to 
Framingham. Compared ATP III, IDF, and WHO definitions all have a 
similar ability to predict CVD & diabetes, but they have differing 
sensitivity and false positive rate. 
et al., 
(2007) 
Loucks,  Cross-sectional study 11107 Used NCEP-R diagnosis criteria; SEP measured by education or 
income is associated with metabolic syndrome in women (white, black, 
and Mexican-American), black women education 12 years, but not <12 
years was linked to metabolic syndrome; mechanisms that link SEP to 
et al., 
(2006) 
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Author 
(Dates) Type N Comments 
metabolic syndrome health behaviors, psychological stress, & access to 
health care. 
Santos, et al. 
(2008) 
Cross-sectional cohort study 1962 Location Portugal, gender influenced the association of socio-economic 
status with metabolic syndrome. Lower socio-economic class defined 
by education and occupation. Females in lower classes increased 
prevalence men no association noted. 
Guize, 
et al. 
(2007) 
Longitudinal cohort study 60754 French study; men aged 52.6 +/- 8.3, women aged 54.7 +/-; mean 
follow-up 3.57 years +/- 1.12; prevalence of metabolic syndrome 
adjusted for age, sex, classical risk factors, socioprofessional standing; 
used ATP III, NCEP-R, and IDF definitions; three and four component 
combinations that showed increased risk of all cause mortality. 
Belahsen & 
Rguibi 
(2006) 
Population N/A Study discussing trends in southern Mediterranean countries with 
reference to diet and activity levels. Away from traditional Med diet 
towards western diet and the increasing incidence of obesity in the area. 
Expert Opinion 
Stone, & 
Schmeltz,  
(2007) 
Expert Opinion N/A Reviewed epidemic of metabolic syndrome and obesity, clinical impact, 
(CVD, DM II, inflammation & prothrombotic state), treatments 
(lifestyle modification, pharmacology, surgery) & expert opinion on 
how to treat metabolic syndrome – treat each of its individual 
components, pharmacologic therapy crucial, but relying solely on 
medications may be counter productive, focus on root causes and start 
with therapeutic lifestyle changes (diet, exercise). 
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Appendix B Patient Profile 
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Appendix C Data Collection Form 
      Participant Number 
Data  Variable
Baseline 30 Days 90 Days 180 Days 
Date     
Age (years)     
Gender     
Smoking status (packs per day)     
Height (inches)     
Weight (pounds)     
Waist circumference (cm)     
Glucose (mmol/l)     
Systolic blood pressure 
(mmHg)  
   
Diastolic blood pressure 
(mmHg)  
   
Triglycerides (mmol/l)     
High-density 
lipoprotein(mmol/l)  
   
Low-density lipoprotein 
(mmol/l)  
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Appendix D Exercise Handout 
Exercise 
 
1. What is physical activity?  
 
Physical activity simply means movement of the body that uses energy. Walking, gardening, 
briskly pushing a baby stroller, climbing the stairs, playing soccer, or dancing the night away are 
all good examples of being active.  
• Moderate physical activities include:  
o Walking briskly (about 3 ½ miles per hour)  
o Hiking  
o Gardening/yard work  
o Dancing  
o Golf (walking and carrying clubs)  
o Bicycling (less than 10 miles per hour)  
o Weight training (general light workout)  
• Vigorous physical activities include:  
o Running/jogging (5 miles per hour)  
o Bicycling (more than 10 miles per hour)  
o Swimming (freestyle laps)  
o Aerobics  
o Walking very fast (4 ½ miles per hour)  
o Heavy yard work, such as chopping wood  
o Weight lifting (vigorous effort)  
o Basketball (competitive)  
Some physical activities are not intense enough to help you meet the recommendations. Although 
you are moving, these activities do not increase your heart rate, so you should not count these 
towards the 45 or more minutes a day that you should strive for. These include walking at a 
casual pace, such as while grocery shopping, and doing light household chores. 
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2. Why is physical activity important? 
Being physically active is a key element in living a longer, healthier, happier life. It can help 
relieve stress and can provide an overall feeling of well-being. Physical activity can also help you 
achieve and maintain a healthy weight and lower risk for chronic disease. The benefits of physical 
activity may include:  
• Improves self-esteem and feelings of well-being  
• Increases fitness level  
• Helps build and maintain bones, muscles, and joints  
• Builds endurance and muscle strength  
• Enhances flexibility and posture  
• Helps manage weight  
• Lowers risk of heart disease, colon cancer, and type 2 diabetes  
• Helps control blood pressure  
• Reduces feelings of depression and anxiety  
Physical activity and nutrition work together for better health. Being active increases the amount 
of calories burned. As people age their metabolism slows, so maintaining energy balance requires 
moving more and eating less. 
Some types of physical activity are especially beneficial:  
• Aerobic activities – speeds heart rate and breathing and improves heart and lung 
fitness. Examples are brisk walking, jogging, and swimming.  
• Resistance, strength building, and weight-bearing activities – helps build and maintain 
bones and muscles by working them against gravity. Examples are carrying a child, 
lifting weights, and walking. They help to build and maintain muscles and bones.  
• Balance and stretching activities – enhances physical stability and flexibility, which 
reduces risk of injuries. Examples are gentle stretching, dancing, yoga, martial arts, 
and t’ai chi.  
3. How much physical activity is needed? 
• At a minimum, do moderate intensity activity for 45 minutes. Try to exercise at least 5 
days a week, but preferably every day. This is in addition to your usual daily activities. 
Increasing the intensity or the amount of time of activity can have additional health 
benefits and may be needed to control body weight. 
• About 60 minutes a day of moderate physical activity may be needed to prevent weight 
gain. For those who have lost weight, at least 60 to 90 minutes a day may be needed to 
maintain the weight loss. At the same time, calorie needs should not be exceeded.  
• While 30 minutes a day of moderate intensity physical activities provide health 
benefits, being active for longer or doing more vigorous activities can provide 
even greater health benefits. They also use up more calories per hour. No 
matter what activity you choose, it can be done all at once, or divided into two 
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or three parts during the day. When dividing exercise during the day 10-minute bouts 
of activity count toward your 45 minute total. 
4. Calories used: 
A 154-pound man (5’ 10”) will use up about the number of calories listed doing each activity 
below. Those who weigh more will use more calories, and those who weigh less will use 
fewer. The calorie values listed include both calories used by the activity and the calories used 
for normal body functioning.  
 
 
Approximate calories used   
by a 154 pound man 
Moderate physical activities:  In 1 hour  In 30 minutes 
 
 370  185 Hiking 
 
Light gardening/yard work  330  165 
 
 330  165 Dancing 
 
Golf (walking and carrying clubs)  330  165 
 
 290  145 Bicycling (less than 10 miles per hour) 
 
Walking (3 ½ miles per hour)  280  140 
 
 220  110 Weight training (general light workout) 
 
Stretching  180  90 
 
Vigorous physical activities:  In 1 hour  In 30 minutes 
 
 590  295 Running/jogging (5 miles per hour) 
 
Bicycling (more than 10 miles per hour)  590  295 
 
 510  255 Swimming (slow freestyle laps) 
 
Aerobics  480  240 
 
 460  230 Walking (4 ½ miles per hour) 
 
Heavy yard work (chopping wood)  440  220 
 
 440  220 Weight lifting (vigorous effort) 
 
Basketball (vigorous)  440  220 
 
5. Tips for increasing physical activity. 
• Make physical activity a regular part of the day. Choose activities that you enjoy and 
can do regularly. Fitting activity into a daily routine can be easy—such as taking a brisk 
10 minute walk to and from the parking lot or bus stop. 
Join an exercise class. Keep it interesting by trying 
something different on alternate days. What’s 
important is to be active most days of the week and make 
it part of daily routine. For example, to reach a 30-
minute goal for the day, walk the dog for 10 minutes 
before and after work, and add a 10 minute walk at 
lunchtime. Swim 3 times a week and take a yoga class 
on the other days. Make sure to do at least 10 minutes of the activity at a time, shorter 
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bursts of activity will not have the same health benefits. To be ready anytime, keep some 
comfortable clothes and a pair of walking or running shoes in the car and at the office. 
• At home: Join a walking group in the neighborhood 
or at the local shopping mall. Recruit a partner for 
support and encouragement. Push the 
baby in a stroller. Get the whole family involved—
enjoy an afternoon bike ride with your kids. Walk 
up and down the soccer or softball field sidelines 
while watching the kids play. Walk the dog—don’t 
just watch the dog walk. Clean the house or wash 
the car. Walk, skate, or cycle more, and drive less. 
Do stretches, exercises, or pedal a stationary bike while watching television. Mow the 
lawn with a push mower. Plant and care for a vegetable or flower garden Play with the 
kids—tumble in the leaves, build a snowman, splash in a puddle, or dance to favorite 
music.  
• At work: Get off the bus or subway one stop early and walk or skate the rest of the 
way. Replace a coffee break with a brisk 10-minute walk. Ask 
a friend to go with you. Take part in an exercise program at 
work or a nearby gym. Join the office softball or bowling team. 
Use the stairs not the elevator. Do not use the closest rest room 
to your office. 
• At play: Walk, jog, skate, or cycle. Swim or do water aerobics. 
Take a class in martial arts, dance, or yoga. Golf (pull cart or 
carry clubs). Canoe, row, or kayak. Play racket ball, tennis, or squash. Ski cross-
country or downhill. Play basketball, softball, or soccer. Hand cycle or play wheelchair 
sports. Take a nature walk. Most important – have fun while being active!  
 
 
 
This handout was adapted from information obtained from 
http://www.mypyramid.gov/pyramid/physical_activity.html
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Appendix E Recommended Servings of Food Groups 
 
Food Group Recommended Servings per Week Serving Size 
Sweets Maximum of 7   1 teaspoon 
Red Meat Maximum of 4  3 ounces 
 
Grains Minimum of 42  1 slice of bread, ½ bagel,  
    1 cup cereal,  
    ½ cup pasta or rice 
Eggs Maximum of 3  1 egg 
Poultry Minimum of 3  3 ounces 
 
Fish Minimum of 3  3 ounces 
 
Wine Minimum of 7  3 – 4 ounces 
 
Olive oil Minimum of 4  1 tablespoon 
 
Fruits Minimum of 21  1 cup fresh, ½ cup canned,  
    ½ cup dried 
 
Beans, legumes, nuts Minimum of 14  Nuts/Seeds 1 ounce, 
    Beans/Legumes ½ cup 
 
Vegetables Minimum of 21  1 cup raw, ½ cup cooked 
 
Cheese & yogurt Minimum of 14  Cheese 1 ounce,  
    Yogurt 1 cup 
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